Inherited Anemias Flashcards

1
Q

______ is an inherited hemoglobinopathy in which a genetic mutation leads to abnormal hemoglobin

A

Sickle Cell Disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Inheritence pattern of sickle cell disease

A

autosomal recessive; most common in those of african descent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

____ black children in the US are born
homozygous for Hgb S (Sickle Cell Disease)

A

1 in 400

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

heterozygous for Hgb S

A

Sickle cell trait

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Pathophysiology of sickle cell disease

A

Hemoglobin S is unstable and will
polymerize in the setting of various stressors, such as hypoxic tissue and acidosis
● This polymerization leads to the
Sickle-shaped RBCs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Sickled cells have difficulty passing through small capillaries, which can lead to ____

A

blockage and tissue necrosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Sickled cells are either destroyed in
peripheral circulation or by the spleen,
resulting in _____

A

Hemolytic Anemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Free Hgb from hemolysis causes ____

A

endothelial dysfunction, vascular injury, and pulmonary hypertension

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Early S/S sickle cell disease

A

● Early signs can include delayed growth and development, fevers, and
splenomegaly
○ Recurrent infections start occurring with hyposplenism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

When is Hgb F present?

A

first 6-12 months of life

Babies born with Sickle Cell Disease present with symptoms at about
6-12 months of age when fetal hemoglobin (Hgb F) is replaced by Hgb S

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Decreased Hgb S affinity for O2 and endovascular damage can cause
_____

A

pulmonary hypertension, CHF, etc.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

How can multi-organ failure occur in sickle cell disease?

A

Repeated episodes of vascular occlusion especially affect the heart, lungs, and liver
○ Multisystem organ failure, heart failure, stroke, and osteonecrosis are all possible and common complications

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Patients with Sickle Cell Trait do not have clinical disease unless they
are exposed to an episode of ____

A

significant hypoxia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Clinical management if a patient presents with a sickle cell crisis

A

○ Hydration (often IV)
○ Generous analgesics
○ Oxygen supplementation
○ Hydroxyurea – reduces the frequency of painful crises, but
has some associated risks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Patients with sickle cell disease should avoid ___ and ____

A

dehydration and hypoxia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

When _____is possible before significant
organ damage, it can cure more than 80% of patients with Sickle Cell
Anemia who have suitable matched donors

A

allogeneic Bone Marrow Transplant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What should you recommend to patients who are heterozygous carriers (sickle cell trait)

A

Genetic counseling

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

With supportive care, average life expectancy for sickle cell disease is now between ____ years of age

A

40-50

19
Q

Thalassemias are hereditary disorders characterized by ____

A

reduction in the synthesis of globin chains (alpha or beta)

20
Q

Reduced globin chain synthesis causes reduced hemoglobin creation and
a ____ because of defective
hemoglobinization of RBCs

A

hypochromic microcytic anemia

21
Q

T/F The inheritance pattern of Thalassemia is not straightforward, being autosomal
dominant for some and recessive for others

A

T

22
Q

Thalassemia overall is most common in families from ____

A

southeast Asia and China, the Mediterranean area, and those of African descent

23
Q

Alpha-Thalassemia:

A

Due to complete loss of one or more of the four
copies of the alpha-globin chain gene

24
Q

Alpha- thalassemia levels

A

○ Loss of 1 - Silent carrier (asymptomatic)
○ Loss of 2 - Alpha-Thalassemia trait (“minor-thalassemia”)
○ Loss of 3 - “Alpha 3”
■ Severe anemia with signs of hemolysis – requires treatment
○ Loss of 4 - Hydrops fetalis (death in utero)
■ No normal alpha hemoglobin is produced

25
Q

Alpha-Thalassemias are seen primarily in persons from ______

A

southeast Asia and
China, and (less commonly) in African and persons of Mediterranean origin

26
Q

Beta-Thalassemia:

A

Due to mutation of promoter sequence for beta-globin chain gene

27
Q

Depending on the type of mutation, the reduced beta-globin
synthesis results in a relative increase in proportions of ____

A

Hgb A2 and Hgb F compared to Hgb A

28
Q

Beta-Thalassemia primarily affects persons of ____

A

Mediterranean origin (such
as Italian, Greek, etc.), and to a lesser extent Asians and African

29
Q

Signs and Symptoms (for both alpha and beta thalassemia)

A

● Clinical presentation can vary significantly and depends on the severity of inherited mutations
● In more mild disease, normal symptoms of anemia may be present (may present like IDA)
● In severe disease, as seen with Alpha-3 or Beta-Major, patients can present with severe anemia, hemolysis, jaundice, hepatosplenomegaly, and significant fatigue

30
Q

Patients with mild disease (Alpha-Thalassemia Trait or
Beta-Thalassemia Minor) require ___

A

no treatment

31
Q

Patients with severe thalassemia are generally maintained on a
regular ____

A

transfusion schedule (every 2-3 weeks)

32
Q

____ is the treatment of choice for
Beta-Thalassemia Major and the only available cure for these patients

A

Allogeneic stem cell transplantation

33
Q

Thalassemia should not be treated with ____

A

iron

34
Q

Glucose-6-Phosphate Dehydrogenase is ____

A

a cytosolic enzyme that
maintains normal cellular levels of another enzyme, NADPH

35
Q

____ is necessary for
maintaining levels of Glutathione
(GSH)

A

NADPH

36
Q

GSH is an important
antioxidant capable of
_____

A

donating an electron to free
radicals

37
Q

G6PD Deficiency is an ____ condition

A

X-Linked Recessive

38
Q

It is the most common human
enzyme defect

A

G6PD deficiency

39
Q

Deficiency of G6PD in RBCs means that the cell cannot handle large
amounts of ____

A

oxidative stress

40
Q

If oxidative stress occurs, the RBCs can’t
stabilize oxidants which results in ____

A

structural damage within the cells

41
Q

Oxidative damage to the cells results in
either spontaneous RBC rupture or
removal by the spleen, causing

A

○ Heinz bodies
○ Bite/blister cells
○ Schistocytes

42
Q

G6PD deficiency results in ____

A

hemolytic anemia

43
Q

In situations of oxidative stress, the patient presents with Hemolytic
Anemia with these S/S

A

○ Fatigue
○ Jaundice
○ Dark urine

44
Q

Clinical management of G6PD deficiency

A

● Treatment generally revolves around treating the infection or removing the offending drug/food
○ No G6PD-specific treatment is necessary
● Full recovery occurs within a matter of weeks
● After recovery, the patient should focus on lifelong avoidance of know triggers